Pure Global AI
NCT06344208Recruiting

Predicting Toxicity in Elderly Patients With Head and Neck Cancer

Predicting Toxicity in Elderly Patients With Head and Neck Cancer: Validating a Disease-oriented Toxicity Predictive Tool and Integrating it With Available Screening Tools for Better Outcomes
European Institute of OncologyClinicalTrials.gov
Verified
Study focus
Disease/Condition
Head and Neck Cancer
Study type
Observational
Sponsor & location
Primary sponsor
European Institute of Oncology
Location
Milan, Italy
Timeline & enrollment
Phase
N/A
Start date
Mar 15, 2022
End date
Dec 31, 2024
Enrollment
3 participants
Primary outcome

Predicting toxicity in elderly patients with head and neck cancer

Summary

Predicting toxicity in elderly patients with head and neck cancer:
 
 validating a disease-oriented toxicity predictive tool and integrating it with avail-able
 screening tools for better outcomes.

ICD-10 classifications
Malignant neoplasm of other and ill-defined sites: Head, face and neckMalignant neoplasm: Skin of scalp and neckMalignant neoplasm: Connective and soft tissue of head, face and neckCarcinoma in situ: Skin of scalp and neckSecondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06344208
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06344208 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 3 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.